Spironolactone improves angiotensin-induced vascular changes and oxidative stress

被引:336
作者
Virdis, A [1 ]
Neves, MF [1 ]
Amiri, F [1 ]
Viel, E [1 ]
Touyz, RM [1 ]
Schiffrin, EL [1 ]
机构
[1] Univ Montreal, Multidisciplinary Res Grp Hypertens, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada
关键词
aldosterone; angiotensin II; endothelium; hypertension; arterial; oxidative stress; remodeling; rats;
D O I
10.1161/01.HYP.0000034738.79310.06
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II plays an important role in vascular remodeling. We investigated the role of aldosterone, which is stimulated by angiotensin II, as a mediator of angiotensin II-induced vascular structural and functional alterations. Sprague-Dawley rats (n=8 to 12/group) received angiotensin II (120 ng/kg per minute, subcutaneously) for 14 days spironolactone or hydralazine (25 mg/kg per day). An additional group received aldosterone (750 ng/h, subcutaneously) +/- spironolactone. Systolic blood pressure was increased by angiotensin II (P<0.001) and reduced by spironolactone and hydralazine (P<0.001). Aldosterone-induced increase of blood pressure was reduced by spironolactone (P<0.05). In mesenteric small arteries studied on a pressurized myograph, media/lumen ratio was increased (P<0.001) and acetylcholine-mediated relaxation was impaired in angiotensin II-infused rats (P<0.001); both were partially improved by spironolactone (P<0.05) but not by hydralazine. Aldosterone-induced increase of media/lumen ratio (P<0.001) and impaired response to acetylcholine (P<0.001) were normalized by spironolactone. Response to sodium nitroprusside was similar in all groups. Aortic NADPH oxidase activity was increased (P<0.01) by angiotensin II and reduced by spironolactone and hydralazine. Aldosterone also increased (P<0.05) activation of NADPH oxidase, an effect abolished by spironolactone. Plasma thiobarbituric acid-reactive substances (a marker of oxidative stress), higher in angiotensin II and aldosterone rats (P<0.001), were normalized by spironolactone. In conclusion, spironolactone, which inhibited aldosterone actions, partially corrected structural and functional angiotensin II-induced abnormalities. These effects were associated with reduced vascular NADPH oxidase activity and decreased plasma markers of oxidative stress. Our findings suggest that aldosterone may mediate some of angiotensin II-induced vascular effects in hypertension, in part via increased oxidative stress.
引用
收藏
页码:504 / 510
页数:7
相关论文
共 41 条
  • [1] ETA receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension
    Barton, M
    d'Uscio, LV
    Shaw, S
    Meyer, P
    Moreau, P
    Lüscher, TF
    [J]. HYPERTENSION, 1998, 31 (01) : 499 - 504
  • [2] Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress
    Cai, H
    Harrison, DG
    [J]. CIRCULATION RESEARCH, 2000, 87 (10) : 840 - 844
  • [3] Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR
    Chen, X
    Touyz, RM
    Park, JB
    Schiffrin, EL
    [J]. HYPERTENSION, 2001, 38 (03) : 606 - 611
  • [4] In vivo study of AT1 and AT2 angiotensin receptors in apoptosis in rat blood vessels
    Diep, QN
    Li, JS
    Schiffrin, EL
    [J]. HYPERTENSION, 1999, 34 (04) : 617 - 624
  • [5] Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis
    Dzau, VJ
    [J]. HYPERTENSION, 2001, 37 (04) : 1047 - 1052
  • [6] Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure
    Farquharson, CAJ
    Struthers, AD
    [J]. CIRCULATION, 2000, 101 (06) : 594 - 597
  • [7] Mineralocorticoid receptor affects AP-1 and nuclear factor-κB activation in angiotensin II-Induced cardiac injury
    Fiebeler, A
    Schmidt, F
    Müller, DN
    Park, JK
    Dechend, R
    Bieringer, M
    Shagdarsuren, E
    Breu, V
    Haller, H
    Luft, FC
    [J]. HYPERTENSION, 2001, 37 (02) : 787 - 793
  • [8] p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats
    Fukui, T
    Ishizaka, N
    Rajagopalan, S
    Lauren, JB
    Capers, Q
    Taylor, WR
    Harrison, DG
    deLeon, H
    Wilcox, JN
    Griendling, KK
    [J]. CIRCULATION RESEARCH, 1997, 80 (01) : 45 - 51
  • [9] NAD(P)H oxidase - Role in cardiovascular biology and disease
    Griendling, KK
    Sorescu, D
    Ushio-Fukai, M
    [J]. CIRCULATION RESEARCH, 2000, 86 (05) : 494 - 501
  • [10] ANGIOTENSIN-II CAUSES VASCULAR HYPERTROPHY IN PART BY A NON-PRESSOR MECHANISM
    GRIFFIN, SA
    BROWN, WCB
    MACPHERSON, F
    MCGRATH, JC
    WILSON, VG
    KORSGAARD, N
    MULVANY, MJ
    LEVER, AF
    [J]. HYPERTENSION, 1991, 17 (05) : 626 - 635